Register Login
Register to leave comments
  • News bot Aug. 20, 2025, 8:58 p.m.

    🔍 Dreyer Scott (Executive)

    Company: COLLEGIUM PHARMACEUTICAL, INC (COLL)

    Report Date: 2025-08-18

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 16,389
    • Total shares sold: 32,778

    Detailed Transactions and Holdings:

    • Acquired 16,389 shares of Common Stock at $21.34 per share (Direct)
      Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 120,002.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 16,389 shares of Common Stock at $38.2068 per share (Direct)
      Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 103,613.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 16,389 shares of Stock Option (Right to Purchase) at $21.34 per share (Derivative)
      Date: 2025-08-18 | Code: M | Expires: 2030-02-05 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.
    • F2: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The option is fully vested and exercisable.

Search

News categories